APO RESEARCH · REPORT
Antibody
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Product & engineering
Understand the product.
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Selected research
Industry Growth & Trends
Global Antibody Industry Growth and Trends Forecast to 2032
Market perspective
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
Read the full market overview
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
Report Scope
This report provides a structured, data-driven view of the global Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Antibody market size, estimates, and forecasts are presented in terms of sales volume (KG) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antibody.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Antibody Market by Company
Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Antibody Segment by Type
IgM
IgG
IgA
Other
Antibody Segment by Application
Therapeutic
Research
Diagnostic
Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- IgM
- IgG
- IgA
- Other
Applications
- Therapeutic
- Research
- Diagnostic
Companies covered
- Roche
- Johnson and Johnson
- Merck
- Novartis
- AbbVie
- Amgen
- Pfizer
- Bayer
- Lilly
- Bristol-Myers Squibb
- GlaxoSmithKline
- Biogen
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Seattle Genetics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Antibody Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Antibody Sales Estimates and Forecasts (2021-2032)
- 1.3 Antibody Market by Type
- 1.3.1 IgM
- 1.3.2 IgG
- 1.3.3 IgA
- 1.3.4 Other
- 1.4 Global Antibody Market Size by Type
- 1.4.1 Global Antibody Market Size Overview by Type (2021-2032)
- 1.4.2 Global Antibody Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Antibody Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Antibody Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Antibody Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Antibody Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Antibody Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Antibody Industry Trends
- 2.2 Antibody Industry Drivers
- 2.3 Antibody Industry Opportunities and Challenges
- 2.4 Antibody Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Antibody Revenue (2021-2026)
- 3.2 Global Top Players by Antibody Sales (2021-2026)
- 3.3 Global Top Players by Antibody Price (2021-2026)
- 3.4 Global Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Antibody Major Company Production Sites & Headquarters
- 3.6 Global Antibody Company, Product Type & Application
- 3.7 Global Antibody Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Antibody Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Antibody Players Market Share by Revenue in 2025
- 3.8.3 2025 Antibody Tier 1, Tier 2, and Tier 3
4 Antibody Regional Status and Outlook
- 4.1 Global Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Antibody Historic Market Size by Region
- 4.2.1 Global Antibody Sales in Volume by Region (2021-2026)
- 4.2.2 Global Antibody Sales in Value by Region (2021-2026)
- 4.2.3 Global Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Antibody Forecasted Market Size by Region
- 4.3.1 Global Antibody Sales in Volume by Region (2027-2032)
- 4.3.2 Global Antibody Sales in Value by Region (2027-2032)
- 4.3.3 Global Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antibody by Application
- 5.1 Antibody Market by Application
- 5.1.1 Therapeutic
- 5.1.2 Research
- 5.1.3 Diagnostic
- 5.2 Global Antibody Market Size by Application
- 5.2.1 Global Antibody Market Size Overview by Application (2021-2032)
- 5.2.2 Global Antibody Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Antibody Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Antibody Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Antibody Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Antibody Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Antibody Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Roche
- 6.1.1 Roche Company Information
- 6.1.2 Roche Business Overview
- 6.1.3 Roche Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Roche Antibody Product Portfolio
- 6.1.5 Roche Recent Developments
- 6.2 Johnson and Johnson
- 6.2.1 Johnson and Johnson Company Information
- 6.2.2 Johnson and Johnson Business Overview
- 6.2.3 Johnson and Johnson Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Johnson and Johnson Antibody Product Portfolio
- 6.2.5 Johnson and Johnson Recent Developments
- 6.3 Merck
- 6.3.1 Merck Company Information
- 6.3.2 Merck Business Overview
- 6.3.3 Merck Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merck Antibody Product Portfolio
- 6.3.5 Merck Recent Developments
- 6.4 Novartis
- 6.4.1 Novartis Company Information
- 6.4.2 Novartis Business Overview
- 6.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Novartis Antibody Product Portfolio
- 6.4.5 Novartis Recent Developments
- 6.5 AbbVie
- 6.5.1 AbbVie Company Information
- 6.5.2 AbbVie Business Overview
- 6.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 AbbVie Antibody Product Portfolio
- 6.5.5 AbbVie Recent Developments
- 6.6 Amgen
- 6.6.1 Amgen Company Information
- 6.6.2 Amgen Business Overview
- 6.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Amgen Antibody Product Portfolio
- 6.6.5 Amgen Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Pfizer Antibody Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 Bayer
- 6.8.1 Bayer Company Information
- 6.8.2 Bayer Business Overview
- 6.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Bayer Antibody Product Portfolio
- 6.8.5 Bayer Recent Developments
- 6.9 Lilly
- 6.9.1 Lilly Company Information
- 6.9.2 Lilly Business Overview
- 6.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Lilly Antibody Product Portfolio
- 6.9.5 Lilly Recent Developments
- 6.10 Bristol-Myers Squibb
- 6.10.1 Bristol-Myers Squibb Company Information
- 6.10.2 Bristol-Myers Squibb Business Overview
- 6.10.3 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Bristol-Myers Squibb Antibody Product Portfolio
- 6.10.5 Bristol-Myers Squibb Recent Developments
- 6.11 GlaxoSmithKline
- 6.11.1 GlaxoSmithKline Company Information
- 6.11.2 GlaxoSmithKline Business Overview
- 6.11.3 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 GlaxoSmithKline Antibody Product Portfolio
- 6.11.5 GlaxoSmithKline Recent Developments
- 6.12 Biogen
- 6.12.1 Biogen Company Information
- 6.12.2 Biogen Business Overview
- 6.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Biogen Antibody Product Portfolio
- 6.12.5 Biogen Recent Developments
- 6.13 AstraZeneca
- 6.13.1 AstraZeneca Company Information
- 6.13.2 AstraZeneca Business Overview
- 6.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 AstraZeneca Antibody Product Portfolio
- 6.13.5 AstraZeneca Recent Developments
- 6.14 Sanofi
- 6.14.1 Sanofi Company Information
- 6.14.2 Sanofi Business Overview
- 6.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Sanofi Antibody Product Portfolio
- 6.14.5 Sanofi Recent Developments
- 6.15 Alexion Pharmaceuticals
- 6.15.1 Alexion Pharmaceuticals Company Information
- 6.15.2 Alexion Pharmaceuticals Business Overview
- 6.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Alexion Pharmaceuticals Antibody Product Portfolio
- 6.15.5 Alexion Pharmaceuticals Recent Developments
- 6.16 Seattle Genetics
- 6.16.1 Seattle Genetics Company Information
- 6.16.2 Seattle Genetics Business Overview
- 6.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Seattle Genetics Antibody Product Portfolio
- 6.16.5 Seattle Genetics Recent Developments
7 North America by Country
- 7.1 North America Antibody Sales by Country
- 7.1.1 North America Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Antibody Sales by Country (2021-2026)
- 7.1.3 North America Antibody Sales Forecast by Country (2027-2032)
- 7.2 North America Antibody Market Size by Country
- 7.2.1 North America Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Antibody Market Size by Country (2021-2026)
- 7.2.3 North America Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Antibody Sales by Country
- 8.1.1 Europe Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Antibody Sales by Country (2021-2026)
- 8.1.3 Europe Antibody Sales Forecast by Country (2027-2032)
- 8.2 Europe Antibody Market Size by Country
- 8.2.1 Europe Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Antibody Market Size by Country (2021-2026)
- 8.2.3 Europe Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Antibody Sales by Country
- 9.1.1 Asia-Pacific Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Antibody Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Antibody Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Antibody Market Size by Country
- 9.2.1 Asia-Pacific Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Antibody Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Antibody Sales by Country
- 10.1.1 South America Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Antibody Sales by Country (2021-2026)
- 10.1.3 South America Antibody Sales Forecast by Country (2027-2032)
- 10.2 South America Antibody Market Size by Country
- 10.2.1 South America Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Antibody Market Size by Country (2021-2026)
- 10.2.3 South America Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Antibody Sales by Country
- 11.1.1 Middle East and Africa Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Antibody Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Antibody Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Antibody Market Size by Country
- 11.2.1 Middle East and Africa Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Antibody Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Antibody Value Chain Analysis
- 12.1.1 Antibody Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Antibody Production Mode & Process
- 12.2 Antibody Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Antibody Distributors
- 12.2.3 Antibody Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst